Related Experiment Videos
Hypereosinophilia associated with intrahepatic cholestasis in early infancy
A M Al-Binali1, S H Al-Fifi, A A Al-Harthi
1Department of Child Health, King Khalid University, PO Box 641, Abha, Kingdom of Saudi Arabia. aalbinali@yahoo.com
Saudi Medical Journal
|May 22, 2001
Insights
A male infant experienced intrahepatic cholestasis caused by unexplained eosinophilia. Prednisone treatment effectively resolved the condition, highlighting its therapeutic potential.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Immunology
Background:
- Intrahepatic cholestasis in infants can have diverse etiologies.
- Idiopathic eosinophilic infiltration of the biliary system is rare.
- Accurate diagnosis is crucial for effective management.
Observation:
- A male infant presented with severe intrahepatic cholestasis.
- Biliary epithelium showed signs of damage attributed to eosinophilic infiltration.
- Extensive investigations ruled out other known causes of cholestasis.
Findings:
- The condition was diagnosed as idiopathic eosinophilia-induced intrahepatic cholestasis.
- The infant showed a significant positive response to prednisone therapy.
- Histopathological examination confirmed eosinophil-mediated biliary injury.
Implications:
- This case underscores the importance of considering eosinophilic disorders in unexplained neonatal cholestasis.
- Prednisone is a viable therapeutic option for this specific condition.
- Further research may elucidate the underlying mechanisms of idiopathic eosinophilic biliary injury.
Abstract:
A male infant presented with intrahepatic cholestasis due to idiopathic eosinophilia damaging the biliary epithelium. No other etiological agent or cause could be identified. He responded well to prednisone therapy.